Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Genitourinary 1

Conditions

Breast Neoplasms 28Colorectal Neoplasms 13Colonic Neoplasms 13Rectal Neoplasms 9Prostatic Neoplasms 7Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Melanoma 5Endometrial Neoplasms 5Central Nervous System Neoplasms 5Ovarian Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Carcinoma, Ovarian Epithelial 4Pancreatic Neoplasms 3Neuroblastoma 3Liver Neoplasms 3Liposarcoma 3Hemangiosarcoma 3Hemangiopericytoma, Malignant 3Gallbladder Neoplasms 3Fibrosarcoma 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Hepatocellular 3

Interventions

bicalutamide 1Testosterone Propionate 1Testosterone 1Tadalafil 1Radiotherapy 1Psychiatric Rehabilitation 1Pilocarpine 1Leuprolide 1Goserelin 1Dehydroepiandrosterone 1Chemotherapy, Adjuvant 1Biofeedback, Psychology 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Sexual Dysfunction, Physiological × Chemotherapy, Adjuvant × Clear all
NCT00541047 2023-11-13

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

University College, London

Phase 3 Completed
4,236 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡